Adeno-Associated Virus-Based Vectors - Viral Vector Approaches in Neurobiology and Brain Diseases - page 47

virus type 2 vectors. Hum Gene Ther 13(16):
1935-1943
55. Zolotukhin S et al (2002) Production and puri-
fication of serotype 1, 2, and 5 recombinant
adeno-associated viral vectors. Methods
28(2):158-167
56. Brument N et al (2002) A versatile and scalable
two-step ion-exchange chromatography pro-
cess for the purification of recombinant adeno-
associated virus serotypes-2 and −5. Mol Ther
6(5):678-686
57. Kaludov N, Handelman B, Chiorini JA (2002)
Scalable purification of adeno-associated virus
type 2, 4, or 5 using ion-exchange chroma-
tography.

associated virus vectors are biologically active
and free of detectable helper and wild-type
viruses. Hum Gene Ther 10(6):1031-1039
61. Clark KR, Voulgaropoulou F, Fraley DM,
Johnson PR (1995) Cell lines for the produc-
tion of recombinant adeno-associated virus.
Hum Gene Ther 6(10):1329-1341
62. Zen Z, Espinoza Y, Bleu T, Sommer JM,
Wright JF (2004) Infectious titer assay for
adeno-associated virus vectors with sensitivity
sufficient to detect single infectious events.
Hum Gene Ther 15(7):709-715
63. Grimm D et al (1999) Titration of AAV-2 par-
ticles via a novel capsid ELISA: packaging of
genomes can limit production of recombinant
AAV-2. Gene Ther 6(7):1322-1330
64. Kuck D, Kern A, Kleinschmidt JA (2007)
Development of AAV serotype-specific ELISAs
using novel monoclonal antibodies. J Virol
Methods 140(1-2):17-24
65. Allen JM, Debelak DJ, Reynolds TC, Miller
AD (1997) Identification and elimination of
replication-competent adeno-associated virus
(AAV) that can arise by nonhomologous
recombination during AAV vector production.
J Virol 71(9):6816-6822

Hum Gene Ther 13(10):

1235-1243
58. Zolotukhin S (2005) Production of recombi-
nant adeno-associated virus vectors. Hum
Gene Ther 16(5):551-557
59. Clark KR, Voulgaropoulou F, Johnson PR
(1996) A stable cell line carrying adenovirus-
inducible rep and cap genes allows for infectiv-
ity titration of adeno-associated virus vectors.
Gene Ther 3(12):1124-1132
60. Clark KR, Liu X, McGrath JP, Johnson PR
(1999) Highly purified recombinant adeno-